Home

Blog

How People Voted

6% For, 94% Against

Take Action

Alert Your Friends and Colleagues
Write Your Representative in Congress
Save & Share
del.icio.us
Digg
Facebook
Google
Reddit
Yahoo!

H.R. 2823, The Fair Balance Prescription Drug Advertisement Act of 2007

  • This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

Comparing original version (created by webmaster) with revision saved on July 19, 2007, 18:21:41 (webmaster):

H.R. 2823 would amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain information or to present information in a balanced manner, it would amend the Federal Food, Drug, and Cosmetic Act to require reports regarding such advertisements, and it would amend such Code to deny any deduction for direct-to-consumer advertisements of qualified prescription drugs for a two-year period.

== Detailed Summary ==

<summary>
(Log inFair Balance Prescription Drug Advertisement Act of 2007 - Amends the Internal Revenue Code to editdisallow a tax deduction for: (1) expenses for direct-to-consumer prescription drug advertising that fails to provide adequate information on drug side effects, contraindications, or lack of effectiveness; and (2) expenses for direct-to-consumer prescription drug advertising of a new drug, a new combination of active substances, or a new delivery system for an existing drug for a two-year period after the wikiintroduction of such drug into interstate commerce.

Amends the Federal Food, Drug,
and beCosmetic Act to require the firstSecretary of Health and Human Services to provide a detailed summaryreport to the Secretary of the bill!)Treasury on misbranding and other violations relating to direct-to-consumer prescription drug advertising.
</summary>

<!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. -->

== Status of the Legislation ==

<status>
(LogLatest Major Action: 6/21/2007: Referred to House committee. Status: Referred to the Committee on Ways and Means, and in addition to edit the wikiCommittee on Energy and Commerce, for a period to be subsequently determined by the first to updateSpeaker, in each case for consideration of such provisions as fall within the statusjurisdiction of the bill!)committee concerned.
</status>

<!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. -->

== Points in Favor ==

(Log in to edit the wiki and be the first to show why the bill should pass!)
<!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! -->

== Points Against ==

(Log in to edit the wiki and be the first to show why the bill should not pass!)
<!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! -->

« Return to Revision History.


Visitor Comments Comments Feed for This Bill

There are currently no comments for this bill.

RSS Feeds for This Bill

Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)